Another option for patients at high OHSS risk is the cryopreservation of embryos or oocytes, and to transfer them in subsequent cycles, regardless of it involving a GnRH agonist cycle or a GnRH antagonist cycle, the GnRH agonist or hCG triggering. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.